L. reuteri
ATCC 55730 is a commercially available probiotic strain
which has been found to carry potentially transferable resistance
traits for tetracycline and lincomycin. Therefore,
it has been replaced by L. reuteri DSM 17938, a strain
where the two resistance plasmids have been removed
without losing any probiotic characteristics [42].